Par Pharma Loses Bid To Keep Appetite Drug Patent
A Maryland federal judge on Friday shut down Par Pharmaceutical Inc.'s bid to keep for itself its formula for a drug that combats anorexia and extreme weight loss in patients with...To view the full article, register now.
Already a subscriber? Click here to view full article